SEC Form 4 · accession 0001179110-16-023932
Theravance Biopharma, Inc. · TBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eran Broshy
Director
Period of report
May 3, 2016
Accepted (ET)
May 5, 2016 · 7:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | May 3, 2016 | A | 6,000 | $0.00 | A | 12,000 | D |
Table II — derivative securities
No Table II lines on this filing.